Regulatory Open Forum

 View Only
  • 1.  Authorized Rep on label

    This message was posted by a user wishing to remain anonymous
    Posted 09-Jul-2021 14:59
    This message was posted by a user wishing to remain anonymous

    Hello RAPS,

    We have a new-generation (software updates) Class II device currently cleared in the US, but not in the EU. The hardware parts and labels have the same part numbers for both generations, and they have the CE Mark and AR information on them. We are reworking to overlabel the CE Mark, and I am saying that we need to overlabel the AR address as well. There is some pushback, as we are nearing commercialization, so I am looking for some evidence to back me up, or prove me wrong. Would this constitute as mislabeling as the new generation is not cleared in the EU yet?


  • 2.  RE: Authorized Rep on label

    Posted 11-Jul-2021 02:12
    Hello Anon,

    Whatever products are placed on the market in the EU need to be compliant with all of the regulations.  If you distribute products in the EU as an entity outside without identifying the Authorised Representative than indeed it would be mis-labelled.  This is a requirement under the MDD, IVDD, EU MDR, and EU IVDR.  If you get push-back just cite the Directive and Regulation where identification of the AR is required.

    ------------------------------
    Richard Vincins RAC
    Vice President Global Regulatory Affairs
    ------------------------------



  • 3.  RE: Authorized Rep on label

    Posted 12-Jul-2021 09:20

    Could you clarify?  Are you asking whether the product that you put on the market in the US would be misbranded in the US due to the presence of the address of the European Authorized Representative because you are not actually marketing in Europe until you have clearance there? 

     

    Naomi J. L. Halpern

    Commercial Counsel

    100 Technology Center Drive | Suite 300

    Stoughton, MA 02072

    Main:  781-713-3699 | Direct: 781-573-3941 | Mobile: 301-807-2574

    nhalpern@collegiumpharma.com

    pronouns: she/her(s)

     

     



    Disclaimer

    The information contained in this communication from the sender is confidential. It is intended solely for use by the recipient and others authorized to receive it. If you are not the recipient, you are hereby notified that any disclosure, copying, distribution or taking action in relation of the contents of this information is strictly prohibited and may be unlawful.

    This email has been scanned for viruses and malware, and may have been automatically archived by Mimecast Ltd, an innovator in Software as a Service (SaaS) for business. Providing a safer and more useful place for your human generated data. Specializing in; Security, archiving and compliance. To find out more Click Here.






  • 4.  RE: Authorized Rep on label

    This message was posted by a user wishing to remain anonymous
    Posted 13-Jul-2021 08:07
    This message was posted by a user wishing to remain anonymous

    Hi Naomi,

    Thank you for your reply; your interpretation is correct. The launch is US only, and I am worried that having the AR info will be seen as the device being cleared for sale in the EU when it is not.


  • 5.  RE: Authorized Rep on label

    This message was posted by a user wishing to remain anonymous
    Posted 13-Jul-2021 17:31
    This message was posted by a user wishing to remain anonymous

    Hi Richard,

    Thank you for your reply - I should have been more clear in the question - the launch is currently US only.

    A couple of factors here to include with the commercialization aspect are - I recently joined, so I haven't had time to build relationships and trust yet, and I am not high on the hierarchy as well, so my voice does not have too much power.


  • 6.  RE: Authorized Rep on label

    This message was posted by a user wishing to remain anonymous
    Posted 12-Jul-2021 08:44
    This message was posted by a user wishing to remain anonymous

    Please correct me if I am wrong, 
    it seems to me like a system HW+SW. While the HW didn't change, the SW did. I don't understand why you need to relabel your HW device at all while you deploy the new SW (which obviously won't be marketed in the EU).
    Please note that if you provide SW as part of the system, you probably have the SW version, and you indicate the CE mark in the SW. If that is the case, you may consider removing the CE from the SW component for the US deployment.  
    Anyway, if you are still going ahead and removing the marking, I suspect that CE and AR go hand in hand. 




  • 7.  RE: Authorized Rep on label

    This message was posted by a user wishing to remain anonymous
    Posted 12-Jul-2021 08:44
    This message was posted by a user wishing to remain anonymous

    ​Is there any chance this device might be carried into Europe?  A properly designated EC REP is legally liable for defective devices, so if something happened to go wrong, they might be unhappy.

    If this version is different enough to need new clearances, it probably has a different UDI, yes?

    From a practical perspective, it's sometimes easiest to have all such info on one ID label, with one review process. Depending on device size and shape, though, the info may be scattered in different places, with nameplates, adhesive labels, silkscreens, and what-have-you. Definitely challenging to manage for compliance.


  • 8.  RE: Authorized Rep on label

    This message was posted by a user wishing to remain anonymous
    Posted 13-Jul-2021 08:08
    This message was posted by a user wishing to remain anonymous

    Hello Anon,

    It certainly is desirable for all the info to be on one label, but the device is large enough to require different labeling materials.
    To answer your question, the chances of it getting carried into Europe are largely negligible.


  • 9.  RE: Authorized Rep on label

    Posted 13-Jul-2021 12:48

    Hi Anon, I would consider leaving the AR without the CE mark as a RA oversight or a 'sloppy typo' and I would insist on fixing it ASAP, but if your team is too close to commercialization, I would ask how soon it will be fixed after the fact, and what is the impact on implementing the change after launching the product.



    ------------------------------
    Yelena Girshman
    Regulatory Affairs Specialist
    Sunnyvale CA
    United States
    ------------------------------